Risk of Neuropsychiatric Disorders After Pediatric Delirium in Children Under 12: A Cohort Study

Ching-Fang Sun1,2, Chih-Sung Liang3, Yingxing Wu4

  • 1Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.

Insights

Pediatric delirium significantly increases the risk of major neuropsychiatric disorders in children. Early recognition and long-term follow-up are crucial for managing these long-term consequences.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Psychiatry

Background:

  • Delirium in adults is linked to long-term neuropsychiatric issues.
  • The impact of pediatric delirium on future mental health remains understudied.

Purpose of the Study:

  • To investigate the long-term risk of major neuropsychiatric disorders following pediatric delirium.
  • To compare the incidence of these disorders in children with and without a history of delirium.

Main Methods:

  • Analysis of de-identified electronic health records from the TriNetX Research network (2013-2023).
  • Inclusion of pediatric patients (<12 years) with and without delirium, matched for demographics and physical comorbidities.
  • Application of Cox regression and Kaplan-Meier analysis to assess neuropsychiatric disorder risk.

Main Results:

  • Pediatric delirium was associated with a 2.15-fold higher risk of neuropsychiatric disorders.
  • 5-year freedom from disorders was 68.5% in the delirium group versus 49.8% in controls.
  • Younger children (≤6 years) with delirium showed higher risks for externalizing disorders, intellectual disability, and ADHD.

Conclusions:

  • Children experiencing delirium face a significantly elevated risk of developing major neuropsychiatric disorders.
  • Healthcare providers should monitor for early signs of neuropsychiatric conditions in pediatric delirium survivors.
  • Awareness and long-term surveillance are essential for managing these risks.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
507
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
960